APO RESEARCH · REPORT
Mebendazole
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
Product & engineering
Understand the product.
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
Selected research
Market Structure
Global Mebendazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.
Mebendazole is widely used for <2 Years Old and >=2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.
Read the full market overview
Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.
This report provides an overview of the global Mebendazole market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Mebendazole and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Mebendazole sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mebendazole market size, projected growth trends, production technologies, key applications, and end-use industries.
Mebendazole Segment by Company
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
Mebendazole Segment by Type
Tablet
Oral Suspension
Mebendazole Segment by Application
Below 2 Years Old
Above 2 Years Old
Mebendazole Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mebendazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mebendazole and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mebendazole.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Mebendazole market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mebendazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mebendazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Mebendazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Oral Suspension
Applications
- Below 2 Years Old
- Above 2 Years Old
Companies covered
- Johnson & Johnson
- Amneal Pharmaceuticals
- Cadila Pharmaceuticals
- Eipico
- Esteve Pharmaceuticals
- Tenry
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Mebendazole Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Mebendazole Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Mebendazole Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Mebendazole Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Mebendazole Market Dynamics
- 2.1 Mebendazole Industry Trends
- 2.2 Mebendazole Industry Drivers
- 2.3 Mebendazole Industry Opportunities and Challenges
- 2.4 Mebendazole Industry Restraints
3 Mebendazole Market by Manufacturers
- 3.1 Global Mebendazole Revenue by Manufacturers (2021-2026)
- 3.2 Global Mebendazole Sales by Manufacturers (2021-2026)
- 3.3 Global Mebendazole Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Mebendazole Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Mebendazole Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Mebendazole Manufacturers, Product Type & Application
- 3.7 Global Mebendazole Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Mebendazole Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Mebendazole Players Market Share by Revenue in 2025
- 3.8.3 2025 Mebendazole Tier 1, Tier 2, and Tier 3
4 Mebendazole Market by Type
- 4.1 Mebendazole Type Introduction
- 4.1.1 Tablet
- 4.1.2 Oral Suspension
- 4.2 Global Mebendazole Sales by Type
- 4.2.1 Global Mebendazole Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Mebendazole Sales by Type (2021-2032)
- 4.2.3 Global Mebendazole Sales Market Share by Type (2021-2032)
- 4.3 Global Mebendazole Revenue by Type
- 4.3.1 Global Mebendazole Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Mebendazole Revenue by Type (2021-2032)
- 4.3.3 Global Mebendazole Revenue Market Share by Type (2021-2032)
5 Mebendazole Market by Application
- 5.1 Mebendazole Application Introduction
- 5.1.1 Below 2 Years Old
- 5.1.2 Above 2 Years Old
- 5.2 Global Mebendazole Sales by Application
- 5.2.1 Global Mebendazole Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Mebendazole Sales by Application (2021-2032)
- 5.2.3 Global Mebendazole Sales Market Share by Application (2021-2032)
- 5.3 Global Mebendazole Revenue by Application
- 5.3.1 Global Mebendazole Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Mebendazole Revenue by Application (2021-2032)
- 5.3.3 Global Mebendazole Revenue Market Share by Application (2021-2032)
6 Global Mebendazole Sales by Region
- 6.1 Global Mebendazole Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Mebendazole Sales by Region (2021-2032)
- 6.2.1 Global Mebendazole Sales by Region (2021-2026)
- 6.2.2 Global Mebendazole Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Mebendazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Mebendazole Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Mebendazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Mebendazole Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Mebendazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Mebendazole Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Mebendazole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Mebendazole Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Mebendazole Revenue by Region
- 7.1 Global Mebendazole Revenue by Region
- 7.1.1 Global Mebendazole Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Mebendazole Revenue by Region (2021-2026)
- 7.1.3 Global Mebendazole Revenue by Region (2027-2032)
- 7.1.4 Global Mebendazole Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Mebendazole Revenue (2021-2032)
- 7.2.2 North America Mebendazole Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Mebendazole Revenue (2021-2032)
- 7.3.2 Europe Mebendazole Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Mebendazole Revenue (2021-2032)
- 7.4.2 Asia-Pacific Mebendazole Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Mebendazole Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Mebendazole Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Johnson & Johnson
- 8.1.1 Johnson & Johnson Company Information
- 8.1.2 Johnson & Johnson Business Overview
- 8.1.3 Johnson & Johnson Mebendazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Johnson & Johnson Mebendazole Product Portfolio
- 8.1.5 Johnson & Johnson Recent Developments
- 8.2 Amneal Pharmaceuticals
- 8.2.1 Amneal Pharmaceuticals Company Information
- 8.2.2 Amneal Pharmaceuticals Business Overview
- 8.2.3 Amneal Pharmaceuticals Mebendazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Amneal Pharmaceuticals Mebendazole Product Portfolio
- 8.2.5 Amneal Pharmaceuticals Recent Developments
- 8.3 Cadila Pharmaceuticals
- 8.3.1 Cadila Pharmaceuticals Company Information
- 8.3.2 Cadila Pharmaceuticals Business Overview
- 8.3.3 Cadila Pharmaceuticals Mebendazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Cadila Pharmaceuticals Mebendazole Product Portfolio
- 8.3.5 Cadila Pharmaceuticals Recent Developments
- 8.4 Eipico
- 8.4.1 Eipico Company Information
- 8.4.2 Eipico Business Overview
- 8.4.3 Eipico Mebendazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Eipico Mebendazole Product Portfolio
- 8.4.5 Eipico Recent Developments
- 8.5 Esteve Pharmaceuticals
- 8.5.1 Esteve Pharmaceuticals Company Information
- 8.5.2 Esteve Pharmaceuticals Business Overview
- 8.5.3 Esteve Pharmaceuticals Mebendazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Esteve Pharmaceuticals Mebendazole Product Portfolio
- 8.5.5 Esteve Pharmaceuticals Recent Developments
- 8.6 Tenry
- 8.6.1 Tenry Company Information
- 8.6.2 Tenry Business Overview
- 8.6.3 Tenry Mebendazole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Tenry Mebendazole Product Portfolio
- 8.6.5 Tenry Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Mebendazole Value Chain Analysis
- 9.1.1 Mebendazole Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Mebendazole Production Mode & Process
- 9.2 Mebendazole Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Mebendazole Distributors
- 9.2.3 Mebendazole Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst